FAMPRIDINE ( DrugBank: Fampridine )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	51
14	慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー	1

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

diseases per page:

Showing 1 to 10 of 51 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-003677-66-NL (EUCTR)	14/02/2022	16/12/2021	Clemastine fumarate as a treament for eye movement disorders in patients with multiple sclerosis	Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple scleros ...	Multiple sclerosis (MS)Internuclear ophthalmoparesis (INO) MedDRA version: 21.0;Level: LLT;Classific ...	Trade Name: Clemastine Milstein 1 mg, tabletten Product Name: Clemastine fumarate INN or Proposed INN: ...	Amsterdam University Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	80	Phase 3	Netherlands
2	NCT03847545 (ClinicalTrials.gov)	December 12, 2018	19/12/2018	Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique	Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking	Multiple Sclerosis	Drug: Fampridine	University of Southern Denmark	Odense University Hospital;Sygehus Lillebaelt;Region of Southern Denmark;The Augustinus Foundation, ...	Completed	18 Years	100 Years	All	48	N/A	Denmark
3	NCT03164018 (ClinicalTrials.gov)	March 7, 2017	29/3/2017	Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis	Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis	Multiple Sclerosis	Drug: Fampridine	Genesis Pharma CNS & Specialty	NULL	Completed	18 Years	N/A	All	111		Greece
4	EUCTR2014-003498-41-AT (EUCTR)	22/09/2015	06/08/2015	Effects of dalfampridine on mobility in the context of daily life	Effects of dalfampridine on mobility in the context of daily life - FampridineStudy in Activities of ...	Motor behaviour and cognition in multiple sclerosis patients;Therapeutic area: Diseases [C] - Nervou ...	Trade Name: Fampyra INN or Proposed INN: FAMPRIDINE	Medical University of Vienna	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Austria
5	NCT01532154 (ClinicalTrials.gov)	August 2015	15/12/2011	Fampridine Pregnancy Exposure Registry	Fampridine Pregnancy Exposure Registry	Multiple Sclerosis;Pregnancy	Drug: Fampridine	Biogen	NULL	Terminated	N/A	N/A	Female	1	N/A	France;Germany;United Kingdom;United States
6	EUCTR2013-003600-40-NL (EUCTR)	20/02/2015	26/11/2014	Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine(BIIB041) 10 mg, Ad ...	A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy a ...	Multiple Sclerosis MedDRA version: 18.0;Level: PT;Classification code 10028245;Term: Multiple sclero ...	Trade Name: Fampyra Product Name: Fampridine Product Code: BIIB041 INN or Proposed INN: FAMPRIDINE	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	590	Phase 3	Serbia;United States;Czech Republic;Finland;Poland;Lithuania;Russian Federation;Bulgaria;Netherlands ...
7	EUCTR2015-000182-31-NL (EUCTR)	11/02/2015	26/01/2015	Study to evaluate the effects of fampridinein patients with multiple sclerosis and eye movement abno ...	A randomized, double-blind, placebo-controlled, cross-over study to assess the effects of fampridine ...	Multiple sclerosis (MS) and a unilateral or bilateral internuclear ophthalmoplegia (INO);Therapeutic ...	Trade Name: Fampyra 10 mg prolonged-release tablets INN or Proposed INN: FAMPRIDINE	CHDR	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
8	EUCTR2013-003600-40-BG (EUCTR)	04/12/2014	17/10/2014	Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine(BIIB041) 10 mg, Ad ...	A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy a ...	Multiple Sclerosis MedDRA version: 18.0;Level: PT;Classification code 10028245;Term: Multiple sclero ...	Trade Name: Fampyra Product Name: Fampridine Product Code: BIIB041 INN or Proposed INN: FAMPRIDINE	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	590	Phase 3	Serbia;United States;Czech Republic;Finland;Poland;Lithuania;Russian Federation;Bulgaria;Netherlands ...
9	EUCTR2013-003600-40-CZ (EUCTR)	22/10/2014	19/06/2014	Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine(BIIB041) 10 mg, Ad ...	A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy a ...	Multiple Sclerosis MedDRA version: 17.1;Level: PT;Classification code 10028245;Term: Multiple sclero ...	Trade Name: Fampyra Product Name: Fampridine Product Code: BIIB041 INN or Proposed INN: FAMPRIDINE	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	590	Phase 3	United States;Serbia;Czech Republic;Finland;Poland;Lithuania;Russian Federation;Bulgaria;Netherlands ...
10	EUCTR2013-003600-40-GB (EUCTR)	15/09/2014	08/05/2014	Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine(BIIB041) 10 mg, Ad ...	A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy a ...	Multiple Sclerosis MedDRA version: 17.0;Level: PT;Classification code 10028245;Term: Multiple sclero ...	Trade Name: Fampyra Product Name: Fampridine Product Code: BIIB041 INN or Proposed INN: FAMPRIDINE	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	590	Phase 3	United States;Serbia;Finland;Ukraine;Lithuania;Russian Federation;United Kingdom;Switzerland;Italy;C ...

First Previous1 2 3 4 5 6Next Last

先頭へ

14. 慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー

臨床試験数 : 175 / 薬物数 : 161 - (DrugBank : 41) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 24

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-002438-34-DK (EUCTR)	19/08/2020	11/06/2020	Fampridine for treatment of functional disability in patients with immune mediated polyneuropathy	Fampridinefor treatment of residual neurological deficits in patients treated with immunoglobulins f ...	Chronic inflammatory demyelinating polyneuropathy MedDRA version: 20.0;Level: LLT;Classification cod ...	Trade Name: Fampyra Product Name: Fampyra INN or Proposed INN: FAMPRIDINE	Department of Neurology, Odense University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	Denmark

First Previous1Next Last

先頭へ